Even as cell and gene therapies inspire hope for patients who previously had none, the path to commercialization is littered with roadblocks. There is a pressing need for increased efficiency, enhanced safety, and innovative approach to pricing and access. How are leading CGTx innovators approaching these challenges? Find out at Cell & Gene Day 2023, a free virtual event, streaming on demand HERE.
Cell & Gene Day 2023 is hosted by Endpoints News and co-sponsored by Precision ADVANCE, Center for Breakthrough Medicines, and Alliance for Regenerative Medicine. Carefully curated, this experience gives you access to the latest thinking on cell and gene therapy research and development, manufacturing, and commercialization. In six panel discussions, you will hear from successful innovators from each facet of the advanced therapy landscape, including leaders from University of Pennsylvania, Blackstone, Alliance for Regenerative Medicine (ARM), Iovance Biotherapeutics, Spark Therapeutics, Kate Therapeutics, RegenXBio, and more. Interested in revisiting some of the content? You can now access the on-demand recordings for any of the 6 sessions here. View now!
- State of the Industry Briefing
- [Moderator] Anshul Mangal: President (Project Farma & Precision ADVANCE)
- Tim Hunt: CEO, ARM
- Next-gen Viral Vectors Take the Spotlight as Safety Frets Persist
- [Moderator] John Carroll: Editor & Founder (Endpoints News)
- The Future is Now: CGTx Innovation, Challenges, and Perspectives
- [Moderator] Anshul Mangal: President (Project Farma & Precision ADVANCE)
- Jim Wilson: Professor, Medicine and Pediatrics & Director, Gene Therapy Program (University of Pennsylvania)
- Bruce Levine: Barbara and Edward Netter Professor, Cancer Gene Therapy (University of Pennsylvania)
- Deborah Phippard: CSO (Precision Value & Health)
- Kiran Reddy: Sr. Managing Director (Blackstone)
- Digitize & Automate to Reduce CGT COGS & Broaden Patient Access
- [Moderator] Audrey Greenberg: Co-Founder & CBO (Center for Breakthrough Medicines)
- John Lee: SVP, Cell Therapy Manufacturing (Center for Breakthrough Medicines)
- Jeet Sarkar: VP, Information Technology (Center for Breakthrough Medicines)
- Joerg Ahlgrimm: CEO (SK Pharmteco)
- Sumit Verma: SVP, Global Strategic Manufacturing (Iovance Biotherapeutics, Inc.)
- Chris Stevens: Chief Patient Supply Officer (Spark Therapeutics, Inc.)
- The Price is Right: Approvals & Market Access in 2023
- [Moderator] Phil Cyr: SVP (Precision Value & Health)
- Chris Kurtz: CMO (Kate Therapeutics)
- Francesca Cook: VP, Market Access (RegenXBio)
- Oswald Bentinck: VP, Global Head of Value & Access (Rocket Pharma)
- Francis Pang: SVP, Global Market Access (Orchard Therapeutics)
- Moving Clinical Development Forward in 2023
- [Moderator] Teresa Pokladowski: Regional VP, Clinical Business Solutions (Precision for Medicine)
- Kanya Rajangam: Head Research & Development | CMO (Senti Bio)
- Robert Ang: CEO (Vor Bio)
- Albert Seymour: President & CEO (Homology Medicines)
- Cristina Musselli: Head of Clinical Development (Abata Therapeutics)
